Plus Therapeutics Inc (PSTV):企業の財務・戦略的SWOT分析

◆英語タイトル:Plus Therapeutics Inc (PSTV) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH4264FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Plus Therapeutics Inc (PSTV) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Plus Therapeutics Inc (Plus Therapeutics), formerly Cytori Therapeutics Inc is a developmental-stage pharmaceutical company, which focuses on the discovery, development, and manufacturing of complex and innovative treatments for patients with cancer and other life-threatening diseases. Its pipeline of candidate drug products includes Doceplus, a patented albumin-stabilized Pegylated liposomal formulation of docetaxel; Doxoplus, a complex, injectable, generic Pegylated liposomal formulation of doxorubicin; BMEDA-chelated rhenium nanoliposome (RNL); and a co-encapsulated, doxorubicin and rhenium nanoliposome (DRNL). It uses a proprietary nanotechnology platform to reformulate and improve conventional chemotherapeutics. Plus Therapeutics is headquartered in Irvine, Texas, the US.

Plus Therapeutics Inc Key Recent Developments

Apr 22,2021: Plus Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights
Feb 22,2021: Plus Therapeutics reports fourth quarter and full year 2020 financial results and business highlights
Feb 11,2021: Plus Therapeutics to Participate in BIO CEO & Investor Digital Conference
Nov 05,2020: Plus Therapeutics announces formation of Scientific Advisory Board
Oct 22,2020: Plus Therapeutics reports third quarter 2020 financial results and business highlights

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Plus Therapeutics Inc – Key Facts
Plus Therapeutics Inc – Key Employees
Plus Therapeutics Inc – Key Employee Biographies
Plus Therapeutics Inc – Major Products and Services
Plus Therapeutics Inc – History
Plus Therapeutics Inc – Company Statement
Plus Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Plus Therapeutics Inc – Business Description
R&D Overview
Plus Therapeutics Inc – Corporate Strategy
Plus Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Plus Therapeutics Inc – Strengths
Plus Therapeutics Inc – Weaknesses
Plus Therapeutics Inc – Opportunities
Plus Therapeutics Inc – Threats
Plus Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Plus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Plus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Plus Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 22, 2021: Plus Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights
Feb 22, 2021: Plus Therapeutics reports fourth quarter and full year 2020 financial results and business highlights
Feb 11, 2021: Plus Therapeutics to Participate in BIO CEO & Investor Digital Conference
Nov 05, 2020: Plus Therapeutics announces formation of Scientific Advisory Board
Oct 22, 2020: Plus Therapeutics reports third quarter 2020 financial results and business highlights
Oct 02, 2020: Plus Therapeutics announces brain cancer clinical advisory team
Aug 10, 2020: Plus Therapeutics reports second quarter 2020 financial and business results
May 14, 2020: Plus Therapeutics reports first quarter 2020 financial and business results
May 12, 2020: Plus Therapeutics announces patient-focused presentation supporting brain tumor awareness month
Apr 06, 2020: Plus Therapeutics donates personal protective equipment to Scripps Health to confront COVID-19 pandemic
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Plus Therapeutics Inc, Key Facts
Plus Therapeutics Inc, Key Employees
Plus Therapeutics Inc, Key Employee Biographies
Plus Therapeutics Inc, Major Products and Services
Plus Therapeutics Inc, History
Plus Therapeutics Inc, Other Locations
Plus Therapeutics Inc, Subsidiaries
Plus Therapeutics Inc, Key Competitors
Plus Therapeutics Inc, Ratios based on current share price
Plus Therapeutics Inc, Annual Ratios
Plus Therapeutics Inc, Annual Ratios (Cont...1)
Plus Therapeutics Inc, Interim Ratios
Plus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Plus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Plus Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Plus Therapeutics Inc (PSTV):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • M+W Group GmbH:企業の戦略・SWOT・財務情報
    M+W Group GmbH - Strategy, SWOT and Corporate Finance Report Summary M+W Group GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Medshape Inc-医療機器分野:企業M&A・提携分析
    Summary Medshape Inc (MedShape), formerly MedShape Solutions Inc is a medical device company that develops and manufactures orthopedic devices for the orthopedic healthcare markets. The company’s products include dynanail ankle arthrodesis nail, eclipse soft tissue anchor, exoshape teno soft tissue …
  • gategroup Holding AG:企業の戦略・SWOT・財務情報
    gategroup Holding AG - Strategy, SWOT and Corporate Finance Report Summary gategroup Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • China Life Insurance Co Ltd:戦略・SWOT・企業財務分析
    China Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • RealPage, Inc.:企業のM&A・事業提携・投資動向
    RealPage, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RealPage, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Biocodex-製薬・医療分野:企業M&A・提携分析
    Summary Biocodex (Biocodex) is a drug manufacturing company that develops and commercializes drugs. The company offers products for gastro enteric diseases, pain management, neurological and psychiatric conditions, rheumatic pains, and ENT conditions. Its products include Saccharomyces boulardii, an …
  • El Paso Electric Company:発電所・企業SWOT分析
    El Paso Electric Company - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Industrija nafte d.d. (INA-R-A):石油・ガス:M&Aディール及び事業提携情報
    Summary Industrija nafte dd (INA) is an integrated energy company, which operates across the energy value chain from exploration and production to refining and marketing to retail. It has interests in offshore and onshore assets in Croatia, Egypt, and Angola. The company manages refineries in Rijeka …
  • PeptiDream Inc (4587):製薬・医療:M&Aディール及び事業提携情報
    Summary PeptiDream Inc (PeptiDream) is a biopharmaceutical company that discovers and develops constrained peptides, small molecule, and peptide-drug conjugate therapeutics. The company develops peptide discovery platform system (PDPS), a peptide generation and selection platform that helps to produ …
  • Transaero, Inc.:企業の戦略・SWOT・財務情報
    Transaero, Inc. - Strategy, SWOT and Corporate Finance Report Summary Transaero, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Cabela’s Incorporated:企業の戦略・SWOT・財務情報
    Cabela's Incorporated - Strategy, SWOT and Corporate Finance Report Summary Cabela's Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • PetroChina Company Limited:企業の戦略・SWOT・財務分析
    PetroChina Company Limited - Strategy, SWOT and Corporate Finance Report Summary PetroChina Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • IOL Chemicals and Pharmaceuticals Ltd (IOLCP):企業の財務・戦略的SWOT分析
    IOL Chemicals and Pharmaceuticals Ltd (IOLCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Hascol Petroleum Ltd (HASCOL):石油・ガス:M&Aディール及び事業提携情報
    Summary Hascol Petroleum Ltd (Hascol) is a petroleum product distributor. The company offers products such as rocket diesel, gasoline, fuel oil, tiger super and furnace oil, and FUCHS lubricants. Its FUCHS lubricants include corrosion preventives, quenching oils, industrial lube, industrial lube, sp …
  • MSIG Insurance (Singapore) Pte. Ltd.:企業の戦略・SWOT・財務情報
    MSIG Insurance (Singapore) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary MSIG Insurance (Singapore) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Chugach Electric Association, Inc.:発電所・企業SWOT分析
    Chugach Electric Association, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information o …
  • HDI-Global SE:企業の戦略・SWOT・財務分析
    HDI-Global SE - Strategy, SWOT and Corporate Finance Report Summary HDI-Global SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Zoo Digital Group plc (ZOO):企業の財務・戦略的SWOT分析
    Summary Zoo Digital Group Plc (ZOO) is a technology company that offers localization and media production services. The company offers services such as subtitling, captioning, dubbing and digital distribution. Its activities include providing a range of services to allow television and movie content …
  • Quantum Fuel Systems LLC (QTWWQ):企業の戦略的SWOT分析
    Quantum Fuel Systems LLC (QTWWQ) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Mahindra & Mahindra Limited:企業の戦略・SWOT・財務情報
    Mahindra & Mahindra Limited - Strategy, SWOT and Corporate Finance Report Summary Mahindra & Mahindra Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆